Here, leading brands such as Ovid, Kluwer, CCH, Lamy, Nelson Thornes, Ipsoa, CT Corporation and Jura will be represented. Plasma screens, work stations and an in-booth theater will present and demonstrate online products such as Books@Ovid, eFacts, R & D Insight, SKOLAR MD, Tymetrix 360°, CCH Wall Street, Lamyline Reflex, Croner-i, Big Unico, CCH@Hand, China Law Express, ProSystem fx and Scientifica. These unique products display Wolters Kluwer's vision of being The Professional's First Choice, by providing information, tools, and solutions to help professionals make their most critical decisions effectively and improve their productivity.
In addition, expert representatives from Wolters Kluwer industry-leading companies will also speak on a number of highly topical subjects, such as:
- Why linking is not an exact science (Ovid Technologies)
- Delivering a community to those who need them most: society portals (Wolters Kluwer Health)
- "The pay-per-view experiment"- dispelling the myths and defining the opportunities (Ovid Technologies)
- Faster new product development using XML-based Enterprise Publishing (Croner CCH Group)
For more information or questions on Wolters Kluwer's presence at this event, please see www.wolterskluwer.com or send an email to info@wolterskluwer.com.
About Wolters Kluwer
Wolters Kluwer is a leading multinational publisher and information services company. The company's core markets are spread across the health, tax, accounting, corporate, financial services, legal and regulatory, and education sectors. Wolters Kluwer has annual revenues (2003) of €3.4 billion, employs approximately 18,750 people worldwide and maintains operations across Europe, North America and Asia Pacific. Wolters Kluwer is headquartered in Amsterdam, the Netherlands. Its depositary receipts of shares are quoted on the Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices.
Media
Caroline Wouters
Vice President, Corporate Communications
t + 31 (0)20 60 70 459
Investor Relations
Oya Yavuz
Vice President, Investor Relations
t + 31 (0) 20 60 70 407
